跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,725 条关于
“obinutuzumab β”
全部
1,725
临床试验
906
药物
280
机构
0
资讯
539
3个月前
Obinutuzumab β (MIL62) Shows 93.1% Relapse Risk Reduction in Phase 3 Trial for AQP4-IgG+ NMOSD
4年前
Acalabrutinib, Venetoclax, and Obinutuzumab Show Promise in Frontline CLL Treatment
14年前
Obinutuzumab Shows Promise in Treating Proliferative Lupus Nephritis
去年
Lenalidomide and Obinutuzumab Combination Shows Promise in Relapsed Non-Hodgkin Lymphoma
去年
Bendamustine-Obinutuzumab Improves Complete Response in Mantle Cell Lymphoma
去年
Atezolizumab, Venetoclax, and Obinutuzumab Show Promise in Richter Transformation DLBCL
10个月前
Rituximab Shows Higher CMV Reactivation Risk Than Obinutuzumab in Follicular Lymphoma Treatment
2年前
Acalabrutinib, Venetoclax, and Obinutuzumab Show Promise in High-Risk CLL
4个月前
Obinutuzumab B-Cell Depletion Significantly Reduces Corticosteroid-Requiring Chronic GVHD in Phase II Trial
3个月前
Obinutuzumab Demonstrates 86% Overall Remission in Refractory Membranous Nephropathy: First Single-Arm Meta-Analysis
第 1 页,共 54 页
上一页
下一页